KINETA, INC./DE (KANT)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch KANT
See up to 3 months of KANT. The 7-day demo opens the 1M and 3M ranges and puts KANT on your watchlist.
Start 7-day demoLatest KANT insider trades
About KINETA, INC./DE (KANT)
KINETA, INC./DE files with the SEC under CIK 0001445283 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
KANT Form 4 activity by transaction type, last 90 days
No Form 4 activity for KANT in the last 90 days.
KANT insider transactions (Form 4)
6911 Form 4 filings on record, the earliest from Jun 23, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shawn Iadonato | Derivative | Common Stock | 860,377 | - | - | |
| Shawn Iadonato | Derivative | Common Stock | 8,553 | - | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 68,233 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 138,767 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 1,213 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 2,426 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 23,879 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 11,466 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 14,677 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 3,440 | $0.00 | - | |
| Shawn Iadonato | Derivative | Stock Option (Right to Buy) | 43,531 | $0.00 | - | |
 Keith Baker - Officer | Derivative | Common Stock | 247,933 | - | - | |
| Keith Baker - Officer | Derivative | Stock Option (Right to Buy) | 2,663 | $0.00 | - | |
| Keith Baker - Officer | Derivative | Stock Option (Right to Buy) | 11,096 | $0.00 | - | |
| Keith Baker - Officer | Derivative | Stock Option (Right to Buy) | 40,037 | $0.00 | - | |
| Keith Baker - Officer | Derivative | Stock Option (Right to Buy) | 80,023 | $0.00 | - | |
 Marion R. Foote | Derivative | Common Stock | 165,156 | - | - | |
| Marion R. Foote | Derivative | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Marion R. Foote | Derivative | Stock Option (Right to Buy) | 3,440 | $0.00 | - | |
| Marion R. Foote | Derivative | Stock Option (Right to Buy) | 6,192 | $0.00 | - | |
| Marion R. Foote | Derivative | Stock Option (Right to Buy) | 10,320 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 688 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 2,064 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 3,965 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 4,634 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 382 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 9,937 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 5,160 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Common Stock | 217,333 | - | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 7,692 | $0.00 | - | |
| Thierry Guillaudeux - Officer | Derivative | Stock Option (Right to Buy) | 112,368 | $0.00 | - | |
 Richard Peters | Derivative | Common Stock | 101,891 | - | - | |
| Richard Peters | Derivative | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Richard Peters | Derivative | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
 Raymond J. Bartoszek | Derivative | Common Stock | 31,000 | - | - | |
| Raymond J. Bartoszek | Derivative | Common Stock | 1,748,473 | - | - | |
| Raymond J. Bartoszek | Derivative | Common Stock | 1,001 | - | - | |
| Raymond J. Bartoszek | Derivative | Common Stock | 1,000 | - | - | |
| Raymond J. Bartoszek | Derivative | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Raymond J. Bartoszek | Derivative | Stock Option (Right to Buy) | 3,440 | $0.00 | - | |
| Raymond J. Bartoszek | Derivative | Stock Option (Right to Buy) | 6,192 | $0.00 | - | |
| Raymond J. Bartoszek | Derivative | Stock Option (Right to Buy) | 10,320 | $0.00 | - | |
| Scott J. Dylla | Derivative | Common Stock | 17,794 | - | - | |
| Scott J. Dylla | Derivative | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| Scott J. Dylla | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Common Stock | 298,464 | - | - | |
| Craig W. Philips - Officer | Derivative | Common Stock | 34,654 | - | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 44,310 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 121,290 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 3,698 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 15,221 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 51,600 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 6,897 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 10,302 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 63 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 1,742 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 3,440 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 29,842 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 3,440 | $0.00 | - | |
| Craig W. Philips - Officer | Derivative | Stock Option (Right to Buy) | 13,760 | $0.00 | - | |
 Kimberlee C. Drapkin | Derivative | Common Stock | 13,794 | - | - | |
| Kimberlee C. Drapkin | Derivative | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| David Arkowitz | Derivative | Common Stock | 16,571 | - | - | |
| David Arkowitz | Derivative | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| David Arkowitz | Derivative | Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| David Arkowitz | Option exercise | Stock Option (Right to Buy) | 12,500 | $0.00 | - | |
| David Arkowitz | Option exercise | Common Stock | 12,500 | $0.61 | $8K | |
| David Arkowitz | Tax withholding / forfeiture | Common Stock | 4,706 | $0.26 | $1K | |
| David Arkowitz | Grant or award | Common Stock | 6,000 | $0.00 | - |
KANT insider trading FAQ
What is the latest insider trade for KANT?
KINETA, INC./DE (KANT) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-06-30. The full record for KANT runs to 11 Form 4 filings, the earliest from 2025-06-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KANT stock?
No insider purchases of KANT were filed in the last 90 days.
How many insiders are selling KANT stock?
No insider sales of KANT were filed in the last 90 days.
Where can I see KANT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KANT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Shawn Iadonato view on EDGAR
- - Keith Baker view on EDGAR
- - Marion R. Foote view on EDGAR
- - Thierry Guillaudeux view on EDGAR
- - Richard Peters view on EDGAR
- - Raymond J. Bartoszek view on EDGAR
- - Scott J. Dylla view on EDGAR
- - Craig W. Philips view on EDGAR
- - Kimberlee C. Drapkin view on EDGAR
- - David Arkowitz view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KANT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KANT with a 7-day demo
- KANT on your watchlist
- Every KANT Form 4 filing on record
- Up to 3 months of KANT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
